〔1〕 SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries〔J〕. CA Cancer J Clin, 2021, 71(3): 209-249.
〔2〕 ZHANG Y S, GAO J Y, BAO Y, et al. Diagnostic Accuracy and Prognostic Significance of Osteopontin in Liver Cirrhosis and Hepatocellular Carcinoma: A Meta-Analysis〔J〕. Biomarkers, 2022, 27(1): 13-21.
〔3〕 DUNN J H, ELLIS L Z, FUJITA M. Inflammasomes as Molecular Mediators of Inflammation and Cancer: Potential Role in Melanoma〔J〕. Cancer Lett,2012,314(1):24-33.
〔4〕 田风, 乔静, 陈雪阳, 等. 细胞焦亡的分子机制及其与恶性肿瘤的关系〔J〕. 中国肿瘤临床, 2020, 47(13): 682-688.
〔5〕 LIN W L, CHEN Y, WU B M, et al. Identification of the Pyroptosis-Related Prognostic Gene Signature and the Associated Regulation Axis in Lung Adenocarcinoma〔J〕. Cell Death Discov, 2021, 7(1): 161.
〔6〕 YE Y, DAI Q J, QI H B. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer〔J〕. Cell Death Discov, 2021, 7(1): 71.
〔7〕 应乐倩, 王德强, 余晖, 等. 基于细胞焦亡与炎症反应相关基因构建肝细胞癌预后风险评估模型及验证〔J〕. 浙江医学, 2022, 44(3): 250-257.
〔8〕 WU Z Y, CHEN L L, JIN C J, et al. A Novel Pyroptosis-Associated Gene Signature for Immune Status and Prog-nosis of Cutaneous Melanoma〔J〕. PeerJ,2021,9: e12304.
〔9〕 GAO L L, LI Q. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer through Interactive Analysis〔J〕. Cancer Manag Res, 2021,13: 7175-7186.
〔10〕 DONG Z, BIAN L, WANG M L, et al. Identification of a Pyroptosis-Related Gene Signature for Prediction of Ove-rall Survival in Lung Adenocarcinoma〔J〕. J Oncol, 2021,2021: 6365459.
〔11〕 SONG W, REN J, XIANG R S, et al. Identification of Pyroptosis-Related Subtypes, the Development of A Prog-nosis Model, and Characterization of Tumor Microen-vironment Infiltration in Colorectal Cancer〔J〕. Oncoim-munology, 2021, 10(1): 1987636.
〔12〕 LIU R, WANG G, ZHANG C, et al. A Prognostic Model for Hepatocellular Carcinoma Based on Apoptosis-Related Genes〔J〕. World J Surg Oncol, 2021, 19(1): 70.
〔13〕 GRASS G D, DAI L, QIN Z Q, et al. CD147: Regulator of Hyaluronan Signaling in Invasiveness and Chemore-sistance〔J〕. Adv Cancer Res, 2014, 123: 351-373.
〔14〕 GALLAGHER S M, CASTORINO J J, PHILP N J. Interaction of Monocarboxylate Transporter 4 with Beta1-Integrin and Its Role in Cell Migration〔J〕. Am J Physiol Cell Physiol, 2009, 296(3): C414-C421.
〔15〕 KANEKURA T, CHEN X. CD147/Basigin Promotes Pro-gression of Malignant Melanoma and other Cancers〔J〕. J Dermatol Sci, 2010, 57(3): 149-154.
〔16〕 SUN J, HEMLER M E. Regulation of MMP-1 and MMP-2 Production through CD147/Extracellular Matrix Metal-loproteinase Inducer Interactions〔J〕. Cancer Res, 2001, 61(5): 2276-2281.
〔17〕 TANG Y, NAKADA M T, KESAVAN P, et al. Extra-cellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases〔J〕. Cancer Res, 2005, 65(8): 3193-3199.
〔18〕 XU Z H, LIU R T, HUANG L, et al. CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Medi-ated Pyroptosis〔J〕. Biomed Res Int, 2020, 2020: 5341247.
〔19〕 JING J S, WANG S C, MA J M, et al. Elevated CTSL2 Expression Is Associated with an Adverse Prognosis in Hepatocellular Carcinoma〔J〕. Int J Clin Exp Pathol, 2018,11(8): 4035-4043.
〔20〕 LENG Y P, CHEN R F, CHEN R T, et al. HMGB1 Mediates Homocysteine-Induced Endothelial Cells Pyrop-tosis via Cathepsin V-Dependent Pathway〔J〕. Biochem Biophys Res Commun, 2020, 532(4):640-646.
〔21〕 SHI F, CAO S L, ZHU Y H, et al. High Expression of DHX9 Promotes the Growth and Metastasis of Hepatocellular Carcinoma〔J〕. J Clin Lab Anal, 2021, 35(12): e24052.
〔22〕 BRIARD B, PLACE D E, KANNEGANTI T D. DNA Sensing in the Innate Immune Response〔J〕. Physiology (Bethesda), 2020, 35(2): 112-124.
〔23〕 XU D F, WANG Y, ZHOU K L, et al. Development and Validation of A Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma〔J〕. Onco Targets Ther, 2020, 13: 8125-8140.
〔24〕 SUZUKI S,SUZUKI T,MIMURO H,et al. Shigella Hijacks the Glomulin-cIAPs-Inflammasome Axis to Promote Inflammation〔J〕. EMBO Rep, 2018, 19(1): 89-101.
〔25〕 GUO X X, LI X P, ZHOU P, et al. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Sup-pressing NOD1 Signal Pathway〔J〕. Int J Mol Sci, 2018, 19(11): 3419.
〔26〕 KUMAR V, KUMAR A, MIR K U I, et al. Pleiotropic Role of PARP1: An Overview〔J〕. 3 Biotech, 2022, 12(1): 3.
〔27〕 NOMURA F, YAGUCHI M, TOGAWA A, et al. Enhan-cement of Poly-Adenosine Diphosphate-Ribosylation in Human Hepatocellular Carcinoma〔J〕. J Gastroenterol Hepatol, 2000, 15(5): 529-535.
〔28〕 SINGH N. Enhanced Poly ADP-Ribosylation in Human Leukemia Lymphocytes and Ovarian Cancers〔J〕. Cancer Lett, 1991, 58(1/2): 131-135.
〔29〕 YALCINTEPE L,TURKER-SENER L,SENER A,et al. Changes in NAD/ADP-Ribose Metabolism in Rectal Cancer〔J〕. Braz J Med Biol Res, 2005, 38(3):361-365.
〔30〕 刘梅, 黄晶, 王军, 等. 碘化钾通过诱导PARP1表达活化NF-κB/NLRP3炎症小体促进甲状腺滤泡细胞焦亡〔J〕. 中华内分泌代谢杂志, 2021, 37(9): 820-829.
〔31〕 ICHIMURA Y,WAGURI S,SOU Y S,et al. Phospho-rylation of P62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy〔J〕. Mol Cell, 2013, 51(5): 618-631.
〔32〕 SAITO T, ICHIMURA Y, TAGUCHI K, et al. P62/Sqstm1 Promotes Malignancy of HCV-Positive Hepa-tocellular Carcinoma through Nrf2-Dependent Metabolic Reprogramming〔J〕. Nat Commun, 2016, 7: 12030.
〔33〕 SUN H F, FENG J G, TANG L L. Function of TREM1 and TREM2 in Liver-Related Diseases〔J〕. Cells, 2020, 9(12): 2626.
〔34〕 RAMACHANDRAN P, DOBIE R, WILSON-KANAMO-RI J R, et al. Resolving the Fibrotic Niche of Human Liver Cirrhosis at Single-Cell Level〔J〕. Nature, 2019, 575(7783): 512-518.
〔35〕 YE Y, SONG Y N, ZHUANG J H, et al. Anticancer Effects of Echinacoside in Hepatocellular Carcinoma Mouse Model and HepG2 Cells〔J〕. J Cell Physiol, 2019, 234(2): 1880-1888.
|